Quarterly Report · 10-Q
FOXO TECHNOLOGIES INC
Quarterly Report
Filed May 15, 2026Accepted May 15, 2026, 10:58 AM EDTCIK 1812360Accession 0001493152-26-023461
Company context
We are a healthcare services and technology company operating in three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs, formerly referred to as Labs and Life. These segments further operate in four synergistic divisions, a rural hospital division and a mental and behavioral health division, which make up our Healthcare segment, a biospecimens division, which makes up our Life Science Services segment and an epigenetics diagnostics and interpretation division, which makes up our Labs segment. Our rural hospital division, biospecimens division and epigenetics diagnostics and interpretation division operate through wholly owned subsidiaries, and our behavioral health division operates through a majority-owned subsidiary.
Current securities
Historical securities (10)
DWINNYSE · EQUITY · Historical · closed Sep 15, 2022DWIN.UNNYSE · UNIT · Historical · closed Sep 15, 2022DWIN.WSNYSE · WARRANT · Historical · closed Sep 15, 2022FOXONYSE_AMERICAN · EQUITY · Historical · closed Aug 12, 2025FOXOOTC · EQUITY · Historical · closed Jul 1, 2026FOXOOTC · EQUITY · Historical · closed Oct 19, 2026FOXODOTC · EQUITY · Historical · closed Jul 30, 2026FOXOWOTC · WARRANT · Historical · closed May 17, 2023FOXOWOTC · WARRANT · Historical · closed Oct 19, 2026FOXO.WSNYSE · WARRANT · Historical · closed Jan 24, 2023 Registered securities in this filing
FOXO TECHNOLOGIES INC. · 10-Q · Filed 2026-05-15
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Class A Common Stock, par value $0.0001
- Symbol
- Not supplied
- Exchange
- Not supplied
- Classification
- COMMON
Filing context
Context: From2026-01-01to2026-03-31
Dimensions: Not supplied
Accession 000149315226023461 · 1 registered-security cover member
Read the exact SEC filing ↗As-filed source
Primary evidence